M2i Life Sciences
Design, formulation and production of complex molecules.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
* | N/A | N/A | Debt |
| Total Funding | 000k | ||
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 16 % | 10 % | 28 % | 20 % | 28 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (25 %) | 22 % | 10 % | 13 % | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
M2i Life Sciences is a forward-thinking company that operates in the agroecological sector, focusing on biocontrol products. The company's main objective is to reconcile economic development with environmental concerns and respectful governance. They have been recognized for their ability to balance these aspects, receiving accolades from the Henri Savall Foundation and ISEOR.
Their business model revolves around the development and sale of biocontrol products, which are natural alternatives to chemical pesticides. These products are used in agriculture to control pests and diseases, making them attractive to clients in the farming industry who are looking to reduce their environmental impact.
M2i Life Sciences has been successful in expanding its portfolio of approved products, having obtained several approvals for its biocontrol products. These approvals include 3 Marketing Authorization Applications (AMM) for finished products, 2 for active pheromone ingredients, and several AMM extensions in Europe. In simple terms, these approvals mean that M2i's products have been officially recognized as safe and effective, allowing them to be marketed and sold to customers.
The company's revenue is generated through the sale of these biocontrol products. As more farmers and agricultural businesses seek to transition to more environmentally friendly practices, the demand for M2i's products is likely to increase, potentially leading to higher revenues for the company.
Keywords: Agroecology, Biocontrol Products, Economic Development, Environmental Concerns, Respectful Governance, Farming Industry, Marketing Authorization Applications, Active Pheromone Ingredients, Environmentally Friendly Practices, Revenue Generation.